As of Mar 16
| +0.0005 / +0.24%|
The 2 analysts offering 12-month price forecasts for ContraVir Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +1,804.76% increase from the last price of 0.21.
The current consensus among 2 polled investment analysts is to Buy stock in ContraVir Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.